SEC 13F Intelligence

Bios Capital Management, LP / RNTX

Bios Capital Management, LP’s Rein Therapeutics Inc Position

Does Bios Capital Management, LP own Rein Therapeutics Inc (RNTX)? Yes — 1.98M shares worth $3M (+4.87% of its 13F portfolio) as of Q1 2026, up from 1.69M shares the prior filed quarter.

Position Value
$3M
Q1 2026
Shares
1.98M
% of Portfolio
+4.87%
Quarters Held
6
currently held

Position History RNTX

Reported value by quarter
Q4 ’24: $4MQ4 ’24Q1 ’25: $3MQ1 ’25Q2 ’25: $2MQ2 ’25Q3 ’25: $2MQ3 ’25Q4 ’25: $2MQ4 ’25Q1 ’26: $3MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.98M$3M+4.87%
Q4 20251.69M$2M+2.37%
Q3 20251.69M$2M+2.19%
Q2 20251.69M$2M+3.26%
Q1 20251.69M$3M+3.78%
Q4 20241.69M$4M+4.13%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bios Capital Management, LP’s full portfolio or all institutional holders of RNTX.